Fangmeng Fu

9PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2026
The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy study.

Yibin Qiu, Long Wu, Weifeng Cai

|Aug 19, 2025
Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy-proven node-positive breast cancer: A prospective study.

Minyan Chen, Zhenhu Lin, Xiaobin Chen

|May 05, 2025
Timing of surgery and 1-year postoperative outcomes in patients with breast cancer and preoperative COVID-19 history: A matched, longitudinal, ambidirectional cohort study.

Yali Wang, Lijuan He, Minyan Chen

|Apr 02, 2024
Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony-stimulating factor following chemotherapy: Triangulation of evidence using population-based cohort and Mendelian randomization analyses.

Yali Wang, Weifeng Cai, Peng He

|Jun 02, 2023
Genetic and lifestyle factors for breast cancer risk assessment in Southeast China.

Shuqing Zou, Yuxiang Lin, Xingxing Yu

|Sep 23, 2020
Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer.

Yan Li, Mingqiang Liang, Yuxiang Lin

Pageof 2

Frequent Collaborators

4 joint publications

Chuan Wang

2 joint publications

Chuan Wang

1 joint publications

Jiaojiao Zhou

1 joint publications

Honglian Wang